Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04377581 · ClinicalTrials.gov registry record
COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 18,251
- Enrollment target
NCT04377581: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT04377581 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 18,251 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04377581 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 18,251 participants
- Enrollment target
Study Summary
Effective communication is a critical component of managing pandemic outbreaks like COVID-19. This study explores COVID-19 related public knowledge, perceptions, belief in public health recommendations, intent to comply with public health recommendations, trust in information sources and preferred information sources. Participants are invited to include detailed free-text answers to make sure their COVID-19 experiences are heard.
Primary Outcome
Binary knowledge measures (true/false questions pertaining to COVID-19) each have a corresponding 5-point confidence score, the inverse of which generates a weighting variable. Weighted knowledge scores will be analyzed via a generalized linear mixed-methods effects model with a logistic link function and a random effect for the participant, generating a probability of correct response from 0 to 1.0.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18,251 participants |
| Start Date | 2020-04-09 |
| Est. Completion | 2020-07-10 |
What the finished NCT04377581 record still lists
NCT04377581 is an observational study that tracks outcomes without assigning an intervention. Its 18,251 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04377581 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04377581 about?
NCT04377581 is a clinical study titled "COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior". Effective communication is a critical component of managing pandemic outbreaks like COVID-19. This study explores COVID-19 related public knowledge, perceptions, belief in public health recommendations, intent to comply with public health recommendations, trust in information sources and preferred i...
What is the current status of trial NCT04377581?
This trial is currently completed. The enrollment target is 18,251 participants. The study started on 2020-04-09. Estimated completion is 2020-07-10.
Who is sponsoring clinical trial NCT04377581?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04372875 · 18,500 participants · NA
Health Information Technology to Reduce Disparities in Adolescent Health Outcomes: A Pragmatic Trial
- NCT04110522 · 18,000 participants · NA
Psoriatic Arthritis D2P Screening
- NCT05513833 · 18,000 participants · NA
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Kentucky
- NCT06802224 · 18,000 participants · Phase 4
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI